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Abstract
p53 protein is a transcription factor involved in multiple tumor-suppressor activities including cell
cycle control and apoptosis. TP53 gene is frequently mutated in glioblastoma, suggesting the
importance of inactivation of this gene product in gliomagenesis. Restoration of p53 function in
glioblastoma cell lines deficient for p53 has shown that p53 induces growth arrest or apoptosis
depending on the cell line and vector used to transduce wild-type TP53 alleles. Considering that
astrocytes grow and express p53, it is not clear whether these results reflect physiologic responses
or the result of p53 overexpression in combination with cellular responses to viral vector infection.
Here, we reassessed this issue using a glioblastoma cell line (LN382) that expresses an endogenous
temperature-sensitive mutant p53. This cell line expresses TP53 alleles (100% as determined by a
p53 transcriptional assay in yeast) mutated at codon 197 GTG (Val) > CTG (Leu). We found that
the p53 protein in these cells acted as an inactive mutant at 37°C and as a functional wild-type p53
below 34°C as demonstrated by several lines of evidence, including (i) restoration of transactivating
ability in yeast, (ii) induction of p53-modulated genes such as CDKN1p21 and transforming growth
factor-α, (iii) disappearance of accumulated p53 protein in the nucleus and (iv) decrease in steady
state p53 protein levels. This temperature switch allowed p53 levels, which were close to
physiological levels to dramatically reduce LN382 cell proliferation by inducing a G1/S cell cycle
block, but not to induce apoptosis. The lack of apoptosis was considered to be a result of the low
level p53 expression, because increasing wild-type p53 levels by adenoviral-mediated gene transfer
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caused apoptosis in these cells. The LN382 cell line will be extremely useful for investigations into
the roles of p53 in cellular responses to a variety of stimuli or damages.
Keywords
p53; temperature-sensitive mutant; cell cycle; growth arrest
TP53 is the most frequently mutated gene in cancer and about 40% of glioblastoma express
mutated p53 protein. The effects of many anti-cancer agents are largely dependent on p53-
mediated apoptosis at the G1/S cell cycle checkpoint subsequent to DNA damage. Therefore,
TP53 status may help stratifying patients into subsets that may respond differently to treatments
such as chemo- and radiotherapy.1,2 Since an inverse relationship between TP53 mutation and
radiosensitivity has been observed in glioblastomas,3 it has been hypothesized that inactivation
of TP53 may confer resistance to radio- and possibly chemotherapeutic agents.4,5 Clearly it is
important to better understand the role of physiologic responses of p53 in these processes for
developing optimal therapeutic strategies for glioma patients.
For studying the role of p53 in these mechanisms, wild-type (WT) p53 function was restored
in various glioblastoma cell lines by several gene transfer methods, including stable
transfection of p53 constructs inducible by dexamethasone6 or tetracycline,7 an exogenous
murine p53 Val 135 temperature-sensitive (ts) mutant,8 p53 expression from retroviruses9 and
adenoviruses.10 Expression of p53 in glioblastoma cells from stably transfected clones or
retrovirally transduced genes induced growth arrest or senescence, whereas expression from
adenoviruses induced apoptosis. Reversibility of the growth arrest was not determined. The
reasons for these uneven responses are unclear but may be linked to variable levels of p53
expression driven by the exogenous promoters used in all these constructs, perturbation of
cellular status by the large difference of culture temperature (6°C) for the exogenous ts mutant,
incomplete function of murine p53 in human cells, variation in p53 responses in different cell
lines and synergy of p53 action with cellular responses to viral infection.
To reassess glioblastoma cell responses to restoration of WT p53 activity close to physiologic
levels, we have taken advantage of our discovery of a glioblastoma cell line (LN382) expressing
a p53 mutant with ts properties in yeast.11 Here we demonstrate that this endogenous p53
mutant switches from mutant to WT activity over a narrow 3°C temperature range (37–34°C)
in LN382 cells, using several assays for p53 activity. Using this cell line, we have subsequently
analyzed changes in cell proliferation and apoptosis in response to p53 activation in the absence
of genotoxic stress. The absolute advantage of using the intrinsic ts mutant over artificially
transfected TP53 genes is that because the ts mutant is under the control of endogenous
TP53 gene regulatory elements its expression level is expected to be in the physiologic range.
Also, the results are not influenced by the selection of a particular clone resistant to cell-cycle
arrest, senescence or apoptosis induced by p53, and does not undergo counterselection of
mutant p53, which occurs rapidly after transfection of WT TP53 alleles.9,12 This cell line thus
will be invaluable in permitting biochemical analyses of the molecular mechanisms underlying
p53 action in a variety of situations.
MATERIAL AND METHODS
Glioblastoma cell lines and culture conditions
Glioblastoma cell line U251MG was maintained with Eagle’s minimal essential medium
(MEM; Gibco-BRL, Grand Island, NY) supplemented with 0.1 mM L-glutamine, 0.1%
NaHCO3, 100 U/ml penicillin-G and 10% fetal calf serum (Gibco-BRL). LN382 cells were
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maintained with DMEM (Gibco-BRL) with the same supplementation. They were cultured at
37°C in a humidified 5% CO2 atmosphere.
p53 transcriptional assay in yeast
p53 transcriptional assay in yeast13 and sequencing of p53 cDNA plasmids recovered from
transfected yeast were performed as described elsewhere.14 To test temperature sensitivity of
the mutant p53 present in LN382 cells, yeast colonies were replated on SDA5HTαα plates13,
14 and cultured at 30°, 34° or 37°C for 2–3 days.
Multiplex reverse transcription-PCR (RT-PCR)
Concentrations of the total RNA extracted from the cells were adjusted at 1 µg/µl and RNA
integrity was verified by electrophoresis in a 1% agarose gel. Each RNA sample (1 µg) was
reverse transcribed at 37°C for 1 hr in a total of 20 µl of the following reaction mixture: 50
mM Tris-HCl, 75 mM KCl, 7.5 mM dithiothreitol, 2.0 mM MgCl2, 0.5 mM each
deoxynucleotide-triphosphate (dNTP), 10 µg/µl random hexamer (pdN6) and 10 U/µl
Moloney-murine leukemia virus (M-MLV) reverse transcriptase (Gibco-BRL). cDNA was
amplified by PCR with 0.05 U/µl AmpliTaq Gold DNA polymerase (Perkin-Elmer, Chiba,
Japan) on a Thermal Cycler Model 2400 (Perkin-Elmer) in a total of 25 µl of the following
reaction mixture: 1.0 µl RT product, 10 mM Tris-HCl, 50 mM KCl, 2 mM MgCl2, 0.2 mM
each dNTP and each primer at the concentration described below. The sequence of the PCR
reaction was an initial denaturation for 10 min at 95°C, followed by 28–30 cycles of
denaturation for 40 sec at 94°C, annealing for 40 sec at 60°C and extension for 60 sec at 72°
C. A final extension was performed for 5 min at 72°C. The 5′ to 3′ sequence of used primer
pairs and their predicted amplicon sizes were for glyceraldehyde 3-phosphate dehydrogenase
(G3PDH): 5′-TGA AGG TCG GAG TCA ACG GAT TTG GT-3′, 5′-CAT GTG GGC CAT
GAG GTC CAC CAC-3′, 983 bp; for Bax: 5′-CAG GAT GCG TCC ACC AAG AAG C-3′,
5′-GGG TGA GGA GGC TTG AGG AGT C-3′, 347 bp; for p21: 5′-GGG GAA GGG ACA
CAC AAG AAG-3′, 5′-GGG GAG CCG AGA GAA AAC AGT-3′, 480 bp; for inducible nitric
oxide synthase (iNOS): 5′-CGG TGC TGT ATT TCC TTA CGA GGC GAA GAA GG-3′, 5′-
GGT GCT GCT TGT TAG GAG GTC AAG TAA AGG GC-3′, 259 bp; for c-jun: 5′-GCA
TGA GGA ACC GCA TCG CTG CCT CCA AGT-3′, 5′-GCG ACC AAG TCC TTC CCA
CTC GTG CAC ACT-3′, 409 bp; for transforming growth factor-α (TGF-α): 5′-ATG GTC
CCC TCG GCT GGA CAG-3′, 5′-GGC CTG CTT CTT CTG GCT GGC-3′, 297 bp; for TGF-
β1: 5′-GCC CTG GAC ACC AAC TAT TGC T-3′, 5′-AGG CTC CAA ATG TAG GGG CAG
G-3′, 161 bp; and for TGF-β2: 5′-GAT TTC CAT CTA CAA GAC CAC GAG GGA CTT
GC-3′, 5′-CAG CAT CAG TTA CAT CGA AGG AGA GCC ATT CG-3′, 503 bp. Each primer
pair concentration versus 0.27 µM G3PDH primers was calibrated for each multiplex PCR
reaction to detect unsaturated amplifications for both amplicons. These values were for Bax
versus G3PDH, 0.3 µM; p21 versus G3PDH, 0.4 µM; for iNOS versus G3PDH, 0.3 µM; for
c-jun versus G3PDH, 0.3 µM; for TGF-α versus G3PDH, 0.4 µM; for TGF-β1 versus G3PDH,
0.3 µM; and for TGF-β2 versus G3PDH, 0.4 µM. PCR products were electrophoresed in a 1%
agarose gel with ethidium bromide staining and photographed under ultraviolet light.
Northern blot analysis
A 495-bp fragment of CDKN1p21 cDNA was amplified by RT-PCR (primers: forward 5′-
ATGTCAGAACCGGCTGGGGATGTCCG-3′, reverse 5′-
TTAGGGCTTCCTCTTGGAGAAGATCA-3′), subcloned into TA cloning vector
(Invitrogen, Carlsbad, CA) and subsequently released with EcoR I and 32P-labeled to make a
probe. U251MG cells and LN382 cells were cultured for 48 hr at either 37° or 34°C, and RNA
were extracted from the cells. RNA were electrophoresed on a formaldehyde/agarose gel and
transferred to a nylon membrane (Hybond-N, Amersham, England). The membrane was
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prehybridized in Hybrisol I (Oncor, Gaithersburg, MD), followed by hybridization with the
CDKN1p21 probe at 42°C overnight. The membrane was washed and exposed to Kodak X-
Omat AR film at −70°C for 4 –24 hr.
Cell growth count
Cells (5 × 104/dish) were plated in a 6-cm diameter Petri dish with 3 ml of culture medium and
left overnight at 37°C to allow cells to adhere to the dish. The next morning the culture was
continued at either 34° or 37°C (day 0). After day 1, duplicate dishes were trypsinized every
day and cells were counted until day 9. For analysis of reversibility of growth arrest, cells (1
× 106/dish) were seeded and allowed to adhere overnight at 37°C, and then cultured (i)
continuously at 37°C, (ii) at 34°C for 24 hr and then 37°C (day 0), (iii) at 34°C for 48 hr and
then at 37°C (day 0) and (iv) continuously at 34°C. The numbers of the cells in triplicate dishes
were counted daily until day 5.
Cell-cycle analysis
Cell cycle was analyzed by flow cytometry using a bromodeoxyuridine-propidium iodide
(BrdU-PI) dual staining technique. Briefly, BrdU to a final concentration of 5 µg/ml was added
to the cells (1 × 106) cultured at each condition in 6-cm dishes, and the cells were incubated
at 37°C for 30 min. The cells were then harvested with trypsin-EDTA treatment, fixed with
70% ethanol, treated with 2 N HCl for 30 min and then neutralized with 0.1 M sodium
tetraborate (pH 8.5). After washing in phosphate-buffered saline (PBS) containing 0.5% Tween
20 (Bio-Rad, Richmond, CA), the cells were incubated with a monoclonal anti-BrdU antibody
(Becton-Dickinson, Lincoln Park, NJ) and then with a fluorescein isothiocyanate-labeled goat
anti-mouse immunoglobulin G (IgG) antibody (Tago, Burlingame, CA), respectively for 30
min at room temperature. After washing with PBS, the cells were incubated with 50 µg/ml PI
for 30 min at 4°C in the dark. Thereafter, the sample was analyzed in a FACSCalibur cytometer
(Becton-Dickinson); 5 × 103 cells were counted per sample.
p53 immunohistochemistry
LN382 or U251MG cells (5 × 104) were seeded on poly-L-lysine-coated glass slides in 2 ml
medium (Becton Dickinson) and precultured at 37°C for 24 hr. The culture was subsequently
continued for the next 24 hr at 34° or 37°C. The cells on the slides were fixed with acetone for
10 min and dried. The slides were treated with a mouse monoclonal anti-p53 protein antibody
DO7 (Dako, Glostrup, Denmark) at a 200-fold dilution and left at 4°C overnight. The staining
was revealed using a streptavidin-biotin complex method with a biotinylated anti-mouse IgG
rabbit polyclonal antibody (Nichirei, Tokyo, Japan), and a Vectastain Elite ABC kit (Vector
Japan, Tokyo). Diaminobenzidine was used as the chromogen. The nuclei were counterstained
with hematoxylin.
p53 ELISA
ELISA for p53 protein was performed using Rapid Format Pan p53 ELISA kit (Calbiochem,
San Diego, CA) according to the manufacturer’s instructions. Protein extracted from duplicate
wells of LN382 or U251MG cells 0, 12, 24, 48 or 72 hr after temperature switch from 37° to
34°C were quantified for p53 content. The p53 concentration (in nanograms) was expressed
per milligrams total cellular protein, which was determined by the use of the BCA protein assay
reagent (Pierce, Rockford, IL) and optical density measurement at 550 nm.
Adenoviral wild-type TP53 gene transfer
To overexpress WT p53 in glioma cells we infected the glioma cells with an adenoviral vector
expressing p53 as described previously. 15 Monolayer cultures of LN382 and U251MG cells
were infected at a multiplicity of infection (m.o.i.) of 100. Adenoviruses expressing luciferase
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(Ad-Luc) or β-galactosidase (Ad-LacZ) were used as a controls. Assay for sub-G0/G1
(apoptotic) cells with flow cytometry (PI staining) was performed 24 hr after the infection.
Generation of a clone expressing stably exogenous coxsackievirus and adenovirus receptor
(CAR) in LN382 cells
Plasmid expressing human CAR cDNA16 was stably transfected into LN382 cells by
CLONfectin (Clontech, Palo Alto, CA). After 400 µg/ml of G418 selection for 2 weeks,
individual clones were isolated, expanded and subjected to screening for efficiency of
adenovirus infection and CAR expression. G418-positive transfectants were infected with 100
m.o.i. of Ad-LacZ virus for 72 hr followed by X-gal and the clones with highest numbers of
blue cells were retained. Subsequently, immunostaining with an anti-CAR antibody (a gift
from Dr. Jeffrey Bergelson) was performed and the clone with highest constitutive and
homogeneous CAR expression was selected and designated LN382/CAR.
Ad-LacZ infection and X-gal staining
Cells of 1 × 105/well in 6-well tissue-culture plates were infected with 100 moi of Ad-LacZ
for 72 hr. Cells were then washed twice with 5 ml cold PBS before fixing with ice cold 0.5%
glutaraldehyde in PBS for 5 min at room temperature. Solution was aspirated and cells were
washed twice with cold PBS before adding 2 ml of X-gal staining solution. After incubation
at 37°C for 24 hr, cells were evaluated for the presence of β-galactosidase-expressing cells
(blue). The X-gal staining solution contained the following reagents: 1.3 mM MgCl2, 15 mM
NaCl, 44 mM Tris, pH 7.4, 3 mMK4Fe(CN)6-3H2O, 3 mMK3Fe(CN)6 and 0.5 mg/ml of X-
gal.
Western blot to detect adenovirally transduced WT p53 protein
LN382 and LN382/CAR cells after 100 moi of Ad-p53 or Ad-LacZ infection for 72 hr at both
34°C and 37°C were harvested and lysed in 1× RIPA buffer (150 mM, 1.0% NP-40, 0.5%
DOC, 0.1% SDS, 50 mM Tris pH 8.0) containing 1× of Complete protease inhibitor cocktail
(Boehringer Mannheim, Indianapolis, IN) in ice for 10 min. Cellular extracts (30 µg) from
each sample were subjected to Western blot analysis. After resolving on a 10% SDS-PAGE,
proteins were transferred to a Hybond ECL nitrocellulose membrane (Amersham, Piscataway,
NJ). The membrane was then hybridized with both mouse monoclonal anti-p53 protein
antibody DO-1 (Santa Cruz Biotechnology, Santa Cruz, CA) and mouse monoclonal anti-actin
antibody (Sigma, St. Louis, MO).
Three-dimensional modeling of Leu197 mutant p53
Three-dimensional (3D) modeling of Leu197 mutant p53 was done using a program Sybil
(Tripos Inc.), applying crystallographic data by Cho et al.17 The χ1 and χ2 angles of the Leu
at position 197 were rotated manually to find the best conformation to fit the space.
RESULTS
Transcriptional activity of the LN382-derived p53 Leu197 mutant in yeast
Glioblastoma cell lines LN382 and U251MG (mutant p53 at amino acid 273, CGG → CAG;
Arg → His) were tested for p53 transcriptional activity in yeast. U251MG cells gave 100%
red colonies, indicating complete inactivation of p53 transcriptional activity of the His273
mutant present in this cell line. LN382 cells gave 100% white colonies with a slight pinkish
haze at 30°C. Sequencing analyses of the p53 cDNA extracted from the yeast colonies
demonstrated that LN382 had a missense mutation at codon 197 (GTG → CTG; Val → Leu)
(Fig. 1a). All colonies had the same mutation, suggesting homozygosity. The slight pinkish
haze present on colonies harboring the Leu197 mutant form of p53 suggested that it might be
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a ts mutant with slightly decreased WT transcriptional activity at 30°C. To test the effect of
temperature on the transcriptional activity of Leu197 mutant, the yeast colonies were cultured
at 30°, 34° and 37°C. The colony color was white at 30°C, pink at 34°C, and red at 37°C (Fig.
1b–d), which indicates that transcriptional activity of Leu197 mutant is abrogated at the higher
temperature. Color of colonies containing the His273 mutant derived from U251MG cells
showed no significant change at any temperature (data not shown).
Transcriptional activity of p53 Leu197 mutant in LN382 glioblastoma cells
To examine whether the temperature modulation of transcriptional activity of the p53 Leu197
mutant observed in yeast is reflected in actual modification of gene expression in LN382 cells,
we performed multiplex RT-PCR on total RNA extracted from LN382 cells grown at 32°, 34°
and 37°C for 24 or 48 hr. mRNA levels were assessed by RT-PCR for genes previously reported
to be upregulated [Bax, CDKN1p21, transforming growth factor-α (TGF-α), TGF-β] or
downregulated (c-fos, c-jun, iNOS) by p53.18–23 Expression of CDKN1p21 and TGF-α was
markedly increased at 34° and 32°C. Bax gene was expressed at a low level at 37°C and its
expression was moderately increased at lower temperatures (Fig. 2a). Except for a slight
reduction in iNOS gene expression 48 hr after temperature change to 32°C, expression of the
other genes did not change significantly at the different temperatures. Induction of
CDKN1p21 mRNA expression was further confirmed by Northern blot analysis. CDKN1p21
mRNA was induced in LN382 when the cells were cultured for 48 hr at 34°C, whereas the
induction was not observed in U251MG cells (Fig. 2b). These results demonstrate that a 3°C
temperature drop restores WT transcription activity to the p53 Leu197 mutant in human cells
and that this activity is not augmented by further temperature decrease to 32°C, in contrast to
what occurred in yeast cells.
p53 protein turnover is temperature dependent in LN382 cells
To test the effect of temperature on p53 Leu197 protein turnover, we measured the amount of
p53 protein in the cells by immunocytochemistry and ELISA at 34° and 37°C. At 37°C, p53
immunocytochemistry showed an accumulation of p53 protein in cell nuclei of LN382 similar
to that in U251MG cells used as positive controls. After the temperature switch to 34°C for 48
hr, immunoreactivity of p53 protein was markedly decreased in LN382 but not in U251MG,
indicating a decline in p53 levels in LN382 cells at 34°C (Fig. 2c–f). ELISA also showed a
significant decrease in p53 protein levels 12–72 hr after switch from 37° to 34°C in LN382
cells, whereas no significant change was observed in U251MG cells (Fig. 2g). These results
show that at 37°C p53 Leu197 mutant accumulate to a level similar to that of mutant His273,
whereas at 34°C it is markedly reduced, suggesting normalization of p53 turnover.
Effects of restoration of WT p53 function on cell growth in LN382 cells
To measure the effects of temperature on cell growth, we cultured LN382 and U251MG cells
at 37° and 34°C, and counted the cell numbers as described in Materials and Methods. At 34°
C, cell growth of LN382 cells was markedly retarded as compared to 37°C, whereas no
significant change was observed in U251MG cells (Fig. 3a).
To examine the cause of growth inhibition in LN382 cells at 34°C, we analyzed the effect of
temperature on cell-cycle progression by flow cytometry using cells treated with BrdU and PI.
This method separates S-phase cells based on BrdU incorporation (vertical axis) and G0/G1
from G2/M cells according to their DNA content measured through PI incorporation (horizontal
axis). LN382 and U251MG cells were analyzed 6, 12, 18, 24 and 48 hr after the temperature
switch to 34°C. Within 6 hr the number of LN382 cells in the G0/G1 phase increased and those
in the S phase decreased (Fig. 3b, left). In concert with the G0/G1 increase there was also an
accumulation of cells in G2/M that culminated at 24 hr. This increase subsided at 48 hr,
paralleled by an increase in S-phase entry. There was no significant difference in the cell-cycle
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phase distribution of U251MG cells in the temperature switch from 37° to 34°C for 48 hr (Fig.
3b, right).
To examine whether the growth arrest was permanent, we incubated LN382 cells for 24 or 48
hr at 34°C and subsequently returned them to 37°C. As a result, we found that the cell growth
arrest was reversible upon restoration of the nonpermissive temperature (Fig. 3c).
Temperature switch does not induce apoptosis in LN382 cells
To determine whether reduction of cellular growth was caused by induction of apoptosis in
LN382 cells at 34°C, we examined DNA fragmentation in LN382 cells and U251MG cells
cultured at 34° and 37°C. Both cell lines did not show any DNA fragmentation at either
temperature (data not shown). Furthermore, no increase of sub-G0/G1 fraction indicative of
apoptosis was observed in flow cytometry (data not shown).
High level expression of WT p53 induces apoptosis in LN382 cells
To delineate the reasons for absence of apoptosis induction in LN382 cells, that is, insufficient
expression or defect(s) in p53-dependent apoptosis pathways in the cells, we transduced WT
p53 with adenoviral gene transfer. By simple infection of p53 adenovirus, LN382 cells did not
undergo apoptosis as assessed by flow-cytometric analysis, whereas massive apoptosis
occurred in U251MG cells (Fig. 4a).
Because adenoviral gene transduction is dependent on cellular expression of CAR,24 we tested
adenoviral infectivity on LN382 cells using adenovirus carrying the β-gal gene. Adenoviral
transduction efficiency was very low both at 37°C and 34°C (Fig. 4b, upper panel). We
therefore transfected the CAR gene into LN382 cells and selected for a stable clone expressing
CAR and infecting at high efficiency with adenovirus (LN382/CAR) (see Material and
Methods). Increased CAR expression was sufficient to significantly augment the efficiency of
Ad-LacZ infection, and consequently LacZ gene transduction and the number of blue cells
after X-gal staining (Fig. 4b, lower panel). In contrast to the cells without CAR transfection,
the cells transfected with CAR underwent apoptosis at both 37° and 34°C by adenoviral WT
p53 gene transfer (Fig. 4c). Furthermore, LN382/CAR cells infected with Ad-LacZ did not die
at 34°C, suggesting that apoptosis is induced by increased p53 levels rather than a synergy of
activation of endogenous p53 with cellular responses to viral infection. Western blot analysis
confirmed a considerably higher level of p53 expression in LN382/CAR cells after adenoviral
WT p53 transfer at both temperatures (Fig. 4d).
3D structure of Leu197 mutant
The effect of a Val to Leu mutation at codon 197 on the 3D structure of p53 protein was
examined using a computer program. Substitution of Val to Leu creates an increased volume
of the side chain: —CH—(CH3)2 to —CH2—CH(CH3)2. The side chain bumped into Val16,
Val216, Val218, Ile232 or Tyr234, according to the rotational angles (χ1 and χ2) of the side
chain. A search for the best conformation disclosed that Leu197 side chain fits the space when
χ1 = 172° and χ2 = 180°. The closest amino acid is Val16 (distance 2.9 Å). Overall, the crystal
structure indicated that the Val to Leu mutation at codon 197 does not directly interfere with
the p53 binding to the DNA, but leads to a structural change that might result in a molecule
with an unstable conformation.
DISCUSSION
In our study we have described a glioblastoma cell line containing an endogenous ts TP53
mutant allele. Transcriptional activity of the Leu197 mutant was restored in the cells by
lowering the culture temperature by only 3°C. With the restoration of WT p53 function, the
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cells completely stopped growing mainly because of G1-phase cell-cycle arrest. A slight
transitional arrest was observed in G2/M, which may have originated from p53’s ability to
inhibit the p34cdc2/cyclin B1 complex.25,26 This growth arrest was reversible upon temperature
rise, indicating that the arrest was mediated by p53’s temperature-dependent transcriptional
activity.
Restoration of WT p53 function induced Bax, CDKN1p21, and TGF-α, whose promoters
contain p53-responsive elements, in agreement with previous reports.18,22,23 It did not induce
TGF-β1 or TGF-β2, which were reported to be induced by WT p53.20 These two genes,
however, are unlikely to be directly regulated by p53, because their promoters do not contain
p53-responsive elements. c-fos and iNOS genes are known to be repressed by WT p53,19,21
among which only a slight repression was observed for iNOS. It may be due to a limitation in
sensitivity of multiplex RT-PCR assay, or a difference in the level of WT p53 expressed (close
to physiologic levels in our present study and extremely high in previous reports using plasmid
vectors).
The restoration of WT function did not induce apoptosis in LN382 cells. Because restoration
of WT p53 function at 34°C induced the Bax gene in LN382 cells, this inability to cause
apoptosis is unlikely to be attributable to incomplete or unbalanced transactivating potential
of p53 Leu197 ts mutant. This cell line did not have a defect in the downstream apoptotic signal
pathway because high levels of WT p53 expression obtained with adenoviral p53 transfer
induced apoptosis in LN382 cells. This effect was not a result of a synergistic effect of
adenovirus infection with endogenous p53 activation, for Ad-LacZ infection did not induce
apoptosis at 34°C. The failure in inducing apoptosis by the restoration of endogenous p53
function at 34°C is thus most likely attributable to the relatively low level of p53 expression
under conditions of normalized protein turnover (Fig. 2c–g). This leads us to an important
insight about proper uses of 2 functions of p53—G1 arrest and apoptosis. A low level expression
of p53 causes G1 arrest, whereas a high level expression causes apoptosis. The latter case might
occur with decreased Mdm2-mediated p53 turnover after phosphorylation on Ser15 and
Ser37,27 or increased transcriptional activity on apoptosis-related gene promoters by site-
specific phosphorylation.28
It should be noted that cold stress can induce certain effects on cellular metabolism, cell growth
and cell death. Such cellular effects have been studied mostly with temperatures less than 20°
C. Such severe hypothermia can change the lipid composition of cellular membranes, and
suppresses the rate of protein synthesis and cell proliferation. Milder hypothermia at 32°C has
been found to induce a cold shock protein, namely CIRP (cold-inducible RNA-binding
protein), which plays an essential role in cold-induced suppression of cell proliferation.29
Whereas CIRP might have contributed to the cellular growth suppression observed in LN382,
it is unlikely to have caused growth arrest per se at 34°C, because the growth and cell cycle of
U251MG cells were barely altered by this modest temperature shift (Fig. 3a,b).
Whereas various mutations at codon 197 have been identified in 14 cases of cancers in diverse
organs,30 only 1 case of lung squamous cell carcinoma has shown a Leu197 mutation31 and
no cell line was established. Intrinsic ts p53 mutants have been described in several other human
cancer cell lines at codons Phe172, Arg214, Cys234, Met272 and Lys285,32,33 but the almost
complete restoration of WT function with a slight change of temperature in LN382 cells as in
our study is unique.
Amino acid 197 is in the S5 β-sheet of the p53 protein next to the H1 loop, which participates
in chelating a Zn atom.17 By 3D-image analysis, we showed that substitution of valine (—CH
—(CH3)2) to leucine (—CH2—CH(CH3)2) caused bumping of the terminal apolar
hydrocarbon (—CH3) of the Leu197 side chain into a distance of less than 4.0 Å to —CH3 of
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either Val16, Val216, Val218, Ile232 or Tyr234, as demonstrated in the 3D-conformational
study. Because the van der Waals radius of —CH3 is 2.0 Å,34 distances between hydrocarbons
of less than 4.0 Å produce repulsive forces between side chains, resulting in slacking of the
folding made by N-terminus and S5-, S6-, S7-, and S8-β sheets. This may or may not affect
Zn binding. In addition, valine (—CH—(CH3)2) and leucine (—CH2—CH(CH3)2) contribute
differently to side chain– helix interactions and thermal stability.35 It is, therefore, conceivable
that the change of Val197 to Leu197 makes an exquisite reversible conformational change
upon only a subtle temperature change. It is intriguing, in this regard, that the prolonged
turnover of the protein in its mutant conformation was rapidly normalized at 34°C, as deduced
from the disappearance of nuclear staining of the protein and the ELISA assay. This finding
suggests that this conformational switch might affect MDM2 binding required for p53 protein
degradation.36,37
In conclusion, we have demonstrated that restoration of endogenous WT p53 activity in
glioblastoma cells arrests their growth in the G0/G1 phase of the cell cycle. This finding is in
contrast to normal human astrocytes in which WT p53 activity does not prevent cell growth.
These results suggest that an endogenous signal present in the cancer cell induces p53 or
synergistically acts with p53 to induce growth arrest. Such a signal might be activation of an
oncogene or DNA damage resulting from genetic instability because both signals are known
to occur in cancer and activate p53-mediated growth arrest.38–40 This endogenous signal is
likely to precede and drive the selection for mutation of the TP53 gene in these cells. This cell
line will be invaluable to define such signals and for further investigations on the role of p53
in cellular responses to variable stimuli or damages, including chemo- and radiotherapies.
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FIGURE 1.
Sequence of the 197Leu p53 mutant and temperature sensitivity of its transcriptional activity
in yeast cells. (a) Sequence chromogram showing a missense mutation [(GTG (Val) → CTG
(Leu), red bar] at codon 197 of the p53 cDNA extracted from yeast colonies that originated
from reverse-transcribed RNA of LN382 human glioblastoma cells. (b)–(d) A yeast colony
containing the 197Leu p53 mutant was replated and cultured at different temperatures. When
expressed in yeast, p53 protein can transactivate the exogenous p53-responsive 3×RGC-CYC
promoter driving the ADE2 gene. This rescues adenine deficiency in the ADE− yeast strain
yIG397 and results in the formation of white colonies. At 37°C (b), the yeast color is red,
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indicating the absence of p53 transcriptional activity. At 34°C (c), pink color shows a partial
transcriptional activity. At 30°C (d), white color indicates a high transcriptional activity of p53.
Ikeda et al. Page 13
Int J Cancer. Author manuscript; available in PMC 2010 February 10.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE 2.
Temperature sensitivity of the p53 Leu197 mutant transcriptional activity in LN382 human
glioblastoma cells. (a) Multiplex reverse transcription-polymerase chain reaction for gene
expression in LN382 cells cultured at different temperatures. G3PDH (glyceraldehyde 3-
phosphate dehydrogenase) was used as an internal control. Lane 1, 37°C; lane 2, 24 hr after
culture at 34°C; lane 3, 48 hr after culture at 34°C; lane 4, 24 hr after culture at 32°C; lane 5,
48 hr after culture at 32°C. The lowest panel shows 18S and 28S rRNA to demonstrate equal
RNA loading of the samples and RNA integrity. (b) Northern blot analysis for mRNA
expression of the CDKN1p21 gene. Lane 1, U251MG cells cultured at 37°C; lane 2, U251 cells
at 34°C; lane 3, LN382 cells at 37°C; lane 4, LN382 cells at 34°C. (c)–(f) Immunocytochemistry
for p53 using DO7 antibody. Nuclear accumulation of p53 protein is observed in LN382
cultured at 37°C and U251MG cells cultured at 34° and 37°C for 48 hr, but not in LN382 cells
cultured at 34°C. (c) LN382, 37°C; (d) LN382, 34°C; (e) U251MG, 37°C; (f) U251MG, 34°
C. (g) Chronological measurement of p53 protein contents by enzyme-linked immunosorbent
assay in U251MG cells (●) and in LN382 cells (■) 12, 24, 48 and 72 hr after switch from 37°
to 34°C.
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FIGURE 3.
Cell growth kinetics and cell cycle progression analyses of LN382 and U251MG cells cultured
at different temperatures. (a) LN382 (left) and U251MG (right) cells were cultured at 37°C
(○) or 34°C (▲) and counted every day for 9 days in duplicate wells (b). The temperature was
switched from 37° to 34°C, and distribution of cells in respective cell cycle phases was
measured at 6, 12, 18, 24 and 48 hr by dual flow cytometry for BrdU and PI. Percentages of
cells in the G0/G1, G2/M and S phases of the cell cycle are plotted separately. The assay was
performed in triplicate dishes and standard deviations are shown. *Statistically significant
difference compared with 0 hr (p < 0.05, t-test). (c) Reversal of cell growth arrest in LN382
cells. Cells were pre-cultured for 24 or 48 hr at 34°C, and culture was continued at 34° or 37°
C from day 0. For control, cells were cultured continuously at 34° or 37°C from day 0. The
number of the cells in triplicate dishes were counted every day until day 5.
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FIGURE 4.
(a) Induction of apoptosis by adenoviral wild-type p53 transfer in U251MG cells but not in
LN382 cells. U251MG cells (A and B) and LN382 cells (C and D) were infected with a
multiplicity of infection of 100 of adenovirus for high level transduction of wild-type p53 (B
and D) or control luciferase genes (A and C). Cells were examined with flow cytometry to
detect sub-G0/G1 apoptotic cells. (b) Increased adenoviral infectivity by forced expression of
coxsackievirus and adenovirus receptor (CAR) in LN382 cells. LN382 cells without CAR
transfection showed low levels of β-gal transduction (upper panels), but LN382 cells with CAR
transfection (lower panels) showed increased transduction efficiencies both at 34° and 37°C.
(Mock, LN382 cells infected with control empty vector.) (c) Induction of apoptosis in LN382
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cells by CAR+ adenoviral p53 transduction. LN382 cells without CAR transfection before
adenoviral β-gal or p53 transduction did not show apoptosis as sub-G1 cells (upper panels),
but cells with CAR plus p53 transduction underwent apoptosis (lower panels). (d) Detection
of a high-level wild-type p53 protein in LN382 cells transfected with CAR and adenoviral p53.
LN382 cells with or without CAR transfection were infected with control empty vector (Mock),
Ad-β-gal vector, or Ad-p53 vector. Cell lysates were electrophoresed in an sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, transferred to nylon membrane, and p53 protein
was detected with a monoclonal antibody.
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FIGURE 5.
Local 3-dimensional structure of the mutant p53 protein around amino acid 197. The normal
structure in gray and the mutant amino-acid (Leu) side chain is superimposed in green.
Distances to the side chains of close amino acids are shown in Angstroms, at the best-fit angles
(χ1 = 172°, χ2 = 180°) of the Leu side chain. Volume increase in the side chain is considered
to produce slacking of the folding made by N-terminus and S5-, S6-, S7- and S8-beta sheets,
leading to an unstable conformation.
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